HOME
ABOUT US
TECHNOLOGY
PRODUCTS
CONTACT US
Biohelix has moved to a new facility.
Quidel and BioHelix enter into a joint development and commercialization agreement.
BioHelix awarded a Cooperative Agreement with NIAID.
Dr. Heiner Dreismann joins BioHelix Board.
Publication on C. difficile
A spin-off from
Privacy, Limitation, Warranty, Disclaimer
